Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Study ID
- NCT06346301
- Status
- Recruiting
Conditions
- Anxiety Disorders
- Body Dysmorphic Disorders
- Obsessive-Compulsive Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Imagery rescripting — BEHAVIORALIn Imagery Rescripting participants imagine a different sequence of events based on missed emotional needs and rescript until needs are fulfilled. Duration of sessions is up to 90 minutes.
Study Details
The goal of this multiple baseline case series study is to test the effect of imagery rescripting (ImRs) in Obsessive Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD). Primary objective :The course of schema or core beliefs and change in OCD and BDD. To investigate the effectiveness of imagery rescripting on factors presumed to underlie the disorder, according to schema theory, and on OCD and BDD symptoms. Secondary objective: The change in OCD and BDD symptoms (full questionnaire), schemata and modes, core emotions, mood, affect and obtrusiveness of intrusion. Other objectives are research into the working mechanisms of imagery rescripting by collecting qualitative data from patients and their practitioner in a qualitative interview. For this study, a multiple-baseline single-case experimental design (SCED) is used testing different outcome variables in 18 OCD patients and 18 BDD patients. After a variable baseline period of 3-8 weeks participants will start twice weekly with imagery rescripting for 12 sessions, followed by a 6 week follow up. Participants will rate schema- or core beliefs and OCD or BDD severity on a visual analogue scale. In addition participants will rate core emotions, affect and obtrusiveness of the intrusion. Secondary we will asses four times questionnaires about OCD of BDD symptoms, depression and schemas en modes. After treatment participants will be interviewed about their experiences.
Key Dates
- First listed
- Apr 4, 2024
- Start date
- Apr 21, 2023
- Status verified
- Apr 2024
- Primary completion
- Jan 31, 2026
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 36 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Imagery RescriptingBaseline consists of a random assigned period of 3-8 weeks with measurements and no intervention. Intervention consists of a maximum of 12 sessions of imagery rescripting, provided twice-weekly. Post treatment follow up consists of 6 weeks with only measurements and no intervention.
Primary Outcome Measure
Schema of core beliefs [ Time Frame: 15-22 weeks ]
Central Contacts
- Tibor van Verseveld+31619624228
- Judy Luigjes
Related Studies
- Study of Neuro-Cognitive Correlates of Pediatric Anxiety DisordersPHASE2 · Recruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland
- Evaluation of Patients With Mood and Anxiety Disorders and Healthy VolunteersRecruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland
- Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety DisordersRecruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland
- Locating Biomarkers in OCD Through Behavioral TasksNot Yet Recruiting · Baylor College of Medicine · Pittsburgh, Pennsylvania